I previously blogged on monthly trading volume here (I updated this chart after January, but I can't easily find it, nor the comments I made at the time). Note that I changed the volume axis to thousands of shares (from the prior number of shares).
I am surprised and unsurprised by the continued drying up of volume. While Network 1 Financial's return in December provided a temporary uptick in volume (it is an important market maker for the stock), management's reporting on the FDA's guidance regarding the SPA process clearly was insufficient (while I think they have the SPA, more importantly, the market does not) and, as I have previously blogged, only more news in March will begin to encourage more eyes to watch the stock.
No comments:
Post a Comment